The global HLA typing market is expected to expand at a compound annual growth rate (CAGR) of approximately 6% during the ...
By Vijay Kumar Malesu Why mismatched resistance thresholds between CLSI and EUCAST could be masking the true scale of ...
TECH is set to report Q2 results on Feb. 4, with EPS seen at 43 cents and revenues at $292M as tariffs, NIH funding and segment shifts shape outlook.